Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashish V Joshi

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2009
Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challengesStephanie R Earnshaw, Michele Wilson, Josephine Mauskopf, et al.
Current Medical Research and Opinion|November 26, 2005
Relationship between obesity and cardiovascular risk factors: findings from a multi-state screening project in the United StatesAshish V Joshi, David Day, Teresa J Lubowski, et al.
Plos One|September 26, 2024
Allergies to antibiotics among US women with uncomplicated urinary tract infectionAshish V Joshi, Alen Marijam, Fanny S Mitrani-Gold, et al.
Stroke|September 30, 2006
Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhageStephanie R Earnshaw, Ashish V Joshi, Michele R Wilson, et al.
Expert Opinion on Pharmacotherapy|May 23, 2007
Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitorsJennifer M Stephens, Ashish V Joshi, Michael Sumner, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 27, 2006
Long-term cost of stroke subtypes among Medicare beneficiariesWon Chan Lee, Michael C Christensen, Ashish V Joshi, et al.
The Journal of Trauma|April 7, 2007
The direct economic burden of blunt and penetrating trauma in a managed care populationKeith L Davis, Ashish V Joshi, Bartholomew J Tortella, et al.
Journal of Patient-Reported Outcomes|April 8, 2021
Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)Regina Rendas-Baum, Nishtha Baranwal, Ashish V Joshi, et al.
Clinical Therapeutics|December 13, 2006
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims dataWon Chan Lee, Sanjeev Balu, David Cobden, et al.
Plos One|February 1, 2023
Activity impairment, health-related quality of life, productivity, and self-reported resource use and associated costs of uncomplicated urinary tract infection among women in the United StatesJeffrey Thompson, Alen Marijam, Fanny S Mitrani-Gold, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2009
Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challengesStephanie R Earnshaw, Michele Wilson, Josephine Mauskopf, et al.
Current Medical Research and Opinion|November 26, 2005
Relationship between obesity and cardiovascular risk factors: findings from a multi-state screening project in the United StatesAshish V Joshi, David Day, Teresa J Lubowski, et al.
Plos One|September 26, 2024
Allergies to antibiotics among US women with uncomplicated urinary tract infectionAshish V Joshi, Alen Marijam, Fanny S Mitrani-Gold, et al.
Stroke|September 30, 2006
Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhageStephanie R Earnshaw, Ashish V Joshi, Michele R Wilson, et al.
Expert Opinion on Pharmacotherapy|May 23, 2007
Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitorsJennifer M Stephens, Ashish V Joshi, Michael Sumner, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 27, 2006
Long-term cost of stroke subtypes among Medicare beneficiariesWon Chan Lee, Michael C Christensen, Ashish V Joshi, et al.
The Journal of Trauma|April 7, 2007
The direct economic burden of blunt and penetrating trauma in a managed care populationKeith L Davis, Ashish V Joshi, Bartholomew J Tortella, et al.
Journal of Patient-Reported Outcomes|April 8, 2021
Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)Regina Rendas-Baum, Nishtha Baranwal, Ashish V Joshi, et al.
Clinical Therapeutics|December 13, 2006
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims dataWon Chan Lee, Sanjeev Balu, David Cobden, et al.
Plos One|February 1, 2023
Activity impairment, health-related quality of life, productivity, and self-reported resource use and associated costs of uncomplicated urinary tract infection among women in the United StatesJeffrey Thompson, Alen Marijam, Fanny S Mitrani-Gold, et al.
Pageof 8